In this patient symposium hosted November 6, 2021 by the Center for Cancer Risk Assessment, speakers discussed screening, prevention, medical management and treatment options for those with gene mutations or those at hereditary risk for pancreatic cancer. The personal impact of learning genetic information was also examined.

1 of 1

Speakers included:

  • Andrew Chan, MD, MPH

    • Chief, Clinical and Translational Epidemiology Unit
    • Director of Cancer Epidemiology, Mass General Cancer Center

  • Daniel Chung, MD

    • Medical Co-Director, Center for Cancer Risk Assessment
    • Director, High-Risk GI Cancer Clinic
    • Professor of Medicine, Harvard Medical School

  • Colin Weekes, MD, PhD

    • Director, Medical Oncology Research for Pancreatic Cancer
    • Director, Cancer Center Grand Rounds Program

  • Kathleen Steinberg, MS, LCGC

    • Senior Genetic Counselor

Related Programs

Type

Centers and Departments

Topics